Literature DB >> 10377065

Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells.

H Kanasaki1, K Fukunaga, K Takahashi, K Miyazaki, E Miyamoto.   

Abstract

We examined whether mitogen-activated protein (MAP) kinase is activated by thyrotropin-releasing hormone (TRH) in GH3 cells, and whether MAP kinase activation is involved in secretion of prolactin from these cells. Protein kinase inhibitors--such as PD098059, calphostin C, and genistein--and removal of extracellular Ca2+ inhibited MAP kinase activation by TRH. A cAMP analogue activated MAP kinase in these cells. Effects of cAMP on MAP kinase activation were inhibited by PD098059. TRH-induced prolactin secretion was not inhibited by levels of PD098059 sufficient to i activation but was inhibited by wortmannin (1 microM) and KN93. Treatment of GH3 cells with either TRH or cAMP significantly inhibited DNA synthesis and induced morphological changes. The effects stimulated by TRH were reversed by PD098059 treatment, but the same effects stimulated by cAMP were not. Treatment of GH3 cells with TRH for 48 h significantly increased the prolactin content in GH3 cells and decreased growth hormone content. The increase in prolactin was completely abolished by PD098059, but the decrease in growth hormone was not. These results suggest that TRH-induced MAP kinase activation is involved in prolactin synthesis and differentiation of GH3 cells, but not in prolactin secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377065     DOI: 10.1095/biolreprod61.1.319

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  6 in total

1.  Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways.

Authors:  Dorota Ptasinska-Wnuk; Hanna Lawnicka; Slawomir Mucha; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  ScientificWorldJournal       Date:  2012-04-24

2.  Secondary amenorrhea in a woman with spinocerebellar degeneration treated with thyrotropin-releasing hormone: a case report and in vitro analysis.

Authors:  Haruhiko Kanasaki; Aki Oride; Tselmeg Mijiddorj; Indri Purwana; Kohji Miyazaki
Journal:  J Med Case Rep       Date:  2011-12-09

Review 3.  Biochemical and physiological insights into TRH receptor-mediated signaling.

Authors:  Radka Trubacova; Zdenka Drastichova; Jiri Novotny
Journal:  Front Cell Dev Biol       Date:  2022-09-06

4.  L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone-induced depolarization in thalamic paraventricular nucleus neurons.

Authors:  Miloslav Kolaj; Li Zhang; Leo P Renaud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-23       Impact factor: 3.619

Review 5.  Interactions between Two Different G Protein-Coupled Receptors in Reproductive Hormone-Producing Cells: The Role of PACAP and Its Receptor PAC1R.

Authors:  Haruhiko Kanasaki; Aki Oride; Tomomi Hara; Tselmeg Mijiddorj; Unurjargal Sukhbaatar; Satoru Kyo
Journal:  Int J Mol Sci       Date:  2016-09-26       Impact factor: 5.923

Review 6.  Role of pituitary adenylate cyclase-activating polypeptide in modulating hypothalamic-pituitary system.

Authors:  Aki Oride; Haruhiko Kanasaki; Satoru Kyo
Journal:  Reprod Med Biol       Date:  2018-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.